What is the difference between an entrepreneur and a serial entrepreneur? Is there a difference? We dig into this question with a four-time hard tech entrepreneur. Mike Moradi is the co-founder and CEO of Sensulin, a company marrying nanotechnology with biotechnology to develop a novel treatment for diabetes that releases insulin on when a patient has high blood sugar.  Mike has founded or helped establish more than a dozen nanotechnology and biotechnology companies, and was selected as a Young Global Leader by the World Economic Forum.

This is the TomorrowScale podcast, hosted by Justin Briggs.

Sensulin: https://www.sensulin.com/

Listen on Your Favorite Podcast App

The TomorrowScale Podcast was created to showcase scientists and entrepreneurs who are building science-based businesses, and to hear their stories from the benches and in the trenches of research & development. The views expressed by the host and guests are their own, and the content of this show should not be considered legal, tax, or investing advice. Thanks to our guests for sharing their time and knowledge with us. Thank you for listening. Please science responsibly.

  • On this episode, our guest is economist Paul Kohlhaas, co-founder and CEO of Molecule and co-author of the VitaDAO whitepaper. We’ll head to Berlin, Germany, where Paul and his team of scientists, engineers, entrepreneurs and enthusiasts who are designing new ways to advance medicines. In Molecule’s case, they’re using tools not from the lab, but [...]

    Continue reading
  • The development of brain-machine or brain-computer interfaces (BCIs) approaches an […]

    Continue reading
  • At the center of every clinical trial is a group […]

    Continue reading
  • On this episode, our guest is economist Paul Kohlhaas, co-founder and CEO of Molecule and co-author of the VitaDAO whitepaper. We’ll head to Berlin, Germany, where Paul and his team of scientists, engineers, entrepreneurs and enthusiasts who are designing new ways to advance medicines. In Molecule’s case, they’re using tools not from the lab, but [...]

    Continue reading
  • The development of brain-machine or brain-computer interfaces (BCIs) approaches an […]

    Continue reading

Leave A Comment